Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Modassir S. Choudhry
Observed names:
M. Choudhry,
Modassir Choudhry,
Modassir S Choudhry
Institution:
Intima Bioscience (United States)
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Harvard University,
Massachusetts General Hospital,
Intima Bioscience (United States)
OpenAlex ID:
A5069447766
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
2022
·
Douglas C. Palmer
, Beau R. Webber
, et al.
·
Med
·
80
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
2025
·
Emil Lou
, Modassir S Choudhry
, et al.
·
The Lancet Oncology
·
62
Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids
2021
·
Mario Mietzsch
, Courtnee Eddington
, et al.
·
Journal of Virology
·
50
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair
2023
·
Beau R. Webber
, Matthew J. Johnson
, et al.
·
Nature Biomedical Engineering
·
27
PDF
Excision of an aneurysm of the left atrial appendage
2007
·
Parsia A. Vagefi
, Modassir Choudhry
, et al.
·
Journal of Thoracic and Cardiovascular Surgery
·
25
PDF
Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
2021
·
Lydia Viney
, Tilmann Bürckstümmer
, et al.
·
Journal of Virology
·
24
333 Targeting the apical intracellular checkpoint CISH unleashes T cell neoantigen reactivity and effector program
2020
·
Douglas Palmer
, Beau Webber
, et al.
·
Regular and Young Investigator Award Abstracts
·
12
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
2020
·
Douglas Palmer
, Beau Webber
, et al.
·
Research Square
·
12
PDF
Genetic editing of CISH enhances T cell effector programs independently of immune checkpoint cell surface ligand expression
2021
·
Elisa Arthofer
, Krishnendu Chakraborty
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
6
PDF
Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics
2021
·
Rohan Sivapalan
, Jinyan Liu
, et al.
·
Scientific Reports
·
6
PDF
Characterization of local inflammatory response in an isolated lung perfusion model
1998
·
Amir Abolhoda
, Ari Brooks
, et al.
·
Annals of Surgical Oncology
·
6
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers
2025
·
Matthew J. Johnson
, Darin Sumstad
, et al.
·
Cytotherapy
·
5
A Bioinformatic and Empiric Exploration of Prokaryotic Argonautes as Novel Programmable Endonuclease Systems
2021
·
Sejla Salic
, Anna Sieber
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints
2026
·
Florencia Cano
, Alberto Bravo-Blas
, et al.
·
Communications Biology
·
1
PDF
CISH, a novel intracellular immune checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints
2025
·
Florencia Cano
, Alberto Bravo Blas
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract CT269: First-in-human trial in patients with metastatic colorectal cancer using CRISPR-engineered tumor infiltrating lymphocytes in which the intracellular immune checkpoint CISH is inhibited
2025
·
Emil Lou
, Modassir S. Choudhry
, et al.
·
Cancer Research
·
1
A genetically engineered, stem-cell-derived cellular vaccine
2022
·
Amanda Cooper
, Adam Sidaway
, et al.
·
Cell Reports Medicine
·
1
Homology mediated end joining enables efficient non-viral targeted integration of large DNA templates in primary human T cells
2021
·
Beau R. Webber
, Matthew J. Johnson
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Bispecific CD20xCD40 Antibodies Achieve Multi-Lineage Modulation of Humoral and Cellular Immunity
2025
·
Ben McLaughlin
, Mark De Boer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
2025
·
Matthew J. Johnson
, Anthony P. DeFeo
, et al.
·
Journal of Visualized Experiments
Gene Editing/Gene Therapies: CLINICAL MANUFACTURE OF CRISPR/CAS9-BASED CYTOKINE-INDUCED SH2 PROTEIN (CISH) KNOCK-OUT (KO) TUMOR-INFILTRATING LYMPHOCYTES (TIL) FOR GASTROINTESTINAL (GI) CANCERS
2022
·
D. Sumstad
, B. Webber
, et al.
·
Cytotherapy
A Novel CRISPR-Engineered, Stem Cell-Derived Cellular Vaccine
2021
·
Krishnendu Chakraborty
, Abishek Chandrashekar
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Internal Checkpoint Regulates T Cell Neoantigen Reactivity and Susceptibility to PD1 Blockade
2020
·
Douglas C. Palmer
, Beau R. Webber
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
23
Citation count:
323
H-index:
8
I10-index:
8
Year
Topic
Type